quinolinic acid has been researched along with Chronic Liver Failure in 1 studies
Quinolinic Acid: A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.
pyridinedicarboxylic acid : Any member of the class of pyridines carrying two carboxy groups.
quinolinic acid : A pyridinedicarboxylic acid that is pyridine substituted by carboxy groups at positions 2 and 3. It is a metabolite of tryptophan.
Excerpt | Relevance | Reference |
---|---|---|
"Quinolinic acid (QuinA) is a tryptophan metabolite produced by activated macrophages." | 5.39 | Increased serum levels of quinolinic acid indicate enhanced severity of hepatic dysfunction in patients with liver cirrhosis. ( Daniel, V; Elhadedy, H; Fusch, G; Iancu, M; Jung, G; Lahdou, I; Mehrabi, A; Opelz, G; Oweira, H; Sadeghi, M; Sandra-Petrescu, F; Schefold, JC; Schmidt, J; Terness, P, 2013) |
"Quinolinic acid (QuinA) is a tryptophan metabolite produced by activated macrophages." | 1.39 | Increased serum levels of quinolinic acid indicate enhanced severity of hepatic dysfunction in patients with liver cirrhosis. ( Daniel, V; Elhadedy, H; Fusch, G; Iancu, M; Jung, G; Lahdou, I; Mehrabi, A; Opelz, G; Oweira, H; Sadeghi, M; Sandra-Petrescu, F; Schefold, JC; Schmidt, J; Terness, P, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lahdou, I | 1 |
Sadeghi, M | 1 |
Oweira, H | 1 |
Fusch, G | 1 |
Daniel, V | 1 |
Mehrabi, A | 1 |
Jung, G | 1 |
Elhadedy, H | 1 |
Schmidt, J | 1 |
Sandra-Petrescu, F | 1 |
Iancu, M | 1 |
Opelz, G | 1 |
Terness, P | 1 |
Schefold, JC | 1 |
1 other study available for quinolinic acid and Chronic Liver Failure
Article | Year |
---|---|
Increased serum levels of quinolinic acid indicate enhanced severity of hepatic dysfunction in patients with liver cirrhosis.
Topics: Adult; Biomarkers; C-Reactive Protein; End Stage Liver Disease; Hepatic Encephalopathy; Humans; Inte | 2013 |